The Early Detection Research Group supports research that seeks to determine the effectiveness, operating characteristics, and clinical impact (harms as well as benefits) of cancer early detection technologies and practices, such as imaging and molecular biomarker approaches.
Read more About the Early Detection Research Group.
PCDC EDRN-APaCC Joint (Virtual) Meeting Registration Now Open
The National Cancer Institute’s Pancreatic Cancer Detection Consortium (PCDC) and Early Detection Research Network – Alliance of Pancreatic Cancer Consortia for Early Detection (EDRN-APaCC) Joint Meeting (Virtual) will take place on December 13, 2021 from 10:30a.m.-5:30p.m. ET. Registration is now open.
Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO)
A large randomized trial designed to determine the effects of screening on cancer-related mortality and secondary endpoints in people aged 55 to 74. Researchers can request valuable PLCO data and biospecimens.
Cancer Data Access System (CDAS)
Submission and tracking for data from the National Lung Screening Trial and the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
The National Lung Screening Trial (NLST)
A lung cancer screening trial that compared two ways of detecting lung cancer: low-dose helical (spiral) computed tomography (CT) and standard chest x-ray. Researchers can request NLST data sets, CT images, and pathology images.